The Broadway landscape shifted significantly during the final full week of April 2025, as a mix of star-driven limited engagements and long-running blockbusters propelled the industry to robust financial figures. At the center of this surge is Daniel Radcliffe, whose performance in the one-person play Every Brilliant Thing has become the season’s most unexpected financial juggernaut. For the week ending April 27, the production brought in a staggering $1.65 million, marking the highest weekly gross for the show since it began its run. This performance not only solidifies Radcliffe’s status as one of Broadway’s most reliable box-office draws but also highlights a growing trend of audience appetite for intimate, interactive theatrical experiences.
Every Brilliant Thing, written by Duncan Macmillan with Jonny Donahoe, is a departure from the traditional proscenium spectacles typically found in the Theater District. The play, which explores themes of mental health and resilience through a list of everything worth living for, relies heavily on audience participation. Despite the inherent risks of such a format, the production has maintained a flawless 100 percent capacity rate. Perhaps most notable is the average ticket price, which climbed to $208.93 last week—the highest in the industry. This premium pricing indicates a high-demand, low-supply environment, as the production likely utilizes a more intimate seating configuration to facilitate its interactive elements.
The Megan Thee Stallion Effect and the Moulin Rouge Transition
While Radcliffe dominated the play category, the musical theater world focused on the Al Hirschfeld Theatre, where Moulin Rouge! The Musical continued its streak of elevated grosses. The production earned $1.64 million last week, securing its position as the fifth highest-grossing show on Broadway. The recent financial revitalization of the 2019 Tony Award winner is largely attributed to the casting of global hip-hop icon Megan Thee Stallion. Her involvement has successfully attracted a younger, more diverse demographic to the theater, a demographic that the Broadway League has been eager to capture in the post-pandemic era.
However, the momentum faces a potential hurdle following a surprise announcement on Monday. Megan Thee Stallion revealed she will be exiting the production earlier than originally anticipated, with her final curtain call set for May 1. This early departure leaves a critical gap in the schedule, as her run was initially slated to continue through May 17. As of this report, the production has not named a replacement for the two-week window between May 2 and May 17. Industry analysts suggest that while the show’s brand remains strong, the absence of a high-profile lead during the peak of the spring season could lead to a temporary dip in ticket sales and average ticket prices.
The Dominance of the Broadway Titans
Despite the headlines generated by celebrity-led limited runs, the top of the leaderboard remains occupied by Broadway’s perennial heavyweights. Harry Potter and the Cursed Child reclaimed its throne as the highest-grossing show of the week, pulling in $2.3 million. The production, which transitioned from a two-part event to a single-show format several seasons ago, continues to benefit from its massive brand recognition and its appeal to international tourists.
Following closely behind were Hamilton and The Lion King, which earned $1.94 million and $1.89 million, respectively. These "Big Three" productions serve as the financial bedrock of the Broadway industry, consistently operating at high capacities regardless of seasonal fluctuations. Their ability to maintain such high grosses years—and in the case of The Lion King, decades—into their runs provides the necessary stability for theater owners to take risks on more experimental or niche productions like Every Brilliant Thing.
Completion of the 2025-2026 Season Cycle
The week ending April 27 marked a historic milestone for the current theatrical year. With the opening of six new productions, the 2025-2026 Broadway season is now officially in full swing. The final wave of openers included a diverse array of genres and source materials:
- Schmigadoon: A stage adaptation of the popular musical comedy television series.
- The Balusters: A new contemporary drama exploring domestic tensions.
- Beaches, The New Musical: A stage version of the beloved novel and film.
- The Rocky Horror Show: A high-energy revival of the cult classic.
- Joe Turner’s Come and Gone: A revival of August Wilson’s masterpiece as part of the ongoing commitment to the American Century Cycle.
- The Lost Boys: A musical adaptation of the 1980s vampire film.
As of April 25, every production slated for this season has officially opened its doors to critics and audiences alike. This synchronization is critical for the industry, as it sets the stage for the most influential event on the theatrical calendar: the Tony Awards.
Strategic Timing and the Tony Nominations Boost
The Broadway community is currently in a state of high anticipation as the Tony Award nominations are scheduled to be announced on May 5. For many of the newly opened productions, a nomination in a major category—such as Best Musical, Best Play, or Best Leading Actor—can be the difference between a long, profitable run and a premature closing.
Historically, the "Tony Bump" can increase a show’s weekly gross by 20 to 40 percent in the weeks following the nominations. Producers often hold back a portion of their marketing budgets specifically for this period, aiming to capitalize on the prestige that comes with award recognition. For shows currently hovering in the middle of the pack financially, such as the star-studded revival of Proof, the upcoming nominations are viewed as a vital lifeline.
Performance of Mid-Tier and New Dramatic Entries
Among the recently opened dramas, Proof is showing significant promise. Starring Academy Award winner Don Cheadle and Emmy winner Ayo Edebiri, the production grossed $976,808 last week. While it did not cross the million-dollar threshold, its 98 percent capacity indicates that it is effectively selling out its venue. The slightly lower gross relative to its capacity suggests a more accessible ticket pricing strategy or a smaller house size, but the high attendance figures bode well for its longevity.
Similarly, the revival of Death of a Salesman, starring theater legends Nathan Lane and Laurie Metcalf, demonstrated strong staying power. The production brought in nearly $1.5 million and played to 90 percent capacity. The pairing of Lane and Metcalf has proven to be a "prestige" draw, attracting serious theatergoers and students of the craft. The $1.5 million figure is particularly impressive for a straight play, which typically lacks the high-ticket-price spectacle of a large-scale musical.
In the musical revival category, Cats: The Jellicle Ball—a reimagining of the Andrew Lloyd Webber classic set within the world of New York City’s ballroom culture—is beginning to find its footing. In its first full week of eight regular performances, the show grossed $1.6 million with 96 percent capacity. This production has benefited from strong word-of-mouth and critical acclaim for its innovative approach to the source material, proving that even well-worn properties can find new life with creative staging.
Financial Vulnerabilities: The Case of Beaches
Not every new production shared in the week’s success. Beaches, The New Musical, currently finds itself in a precarious financial position. While the show managed to increase its capacity to 64 percent last week, its total gross remained a modest $476,871. In the high-stakes environment of Broadway, where weekly operating costs for a musical can easily exceed $600,000 to $800,000, these figures are a cause for concern.
Industry experts suggest that Beaches will need a significant "Tony boost" or a major shift in its marketing strategy to achieve financial sustainability. The show’s current trajectory mirrors that of many "mid-range" musicals that struggle to compete with established blockbusters and star-driven limited runs. Without a surge in attendance or a higher average ticket price, the production may face an uphill battle to remain open through the summer months.
Industry Implications and Future Outlook
The data from the past week suggests a Broadway industry that is increasingly bifurcated. On one side, there is a "super-class" of productions—the long-running hits and the high-wattage star vehicles—that command premium prices and maintain full houses. On the other side, new works without household-name stars or massive intellectual property backing struggle to find an audience in a crowded market.
The average ticket price of $208.93 for Every Brilliant Thing is a milestone that reflects the evolving economics of the theater. Producers are finding that audiences are willing to pay a premium for "event" theater—performances that offer something beyond a passive viewing experience. As Daniel Radcliffe continues his record-breaking run, other producers may look to replicate this model of high-engagement, limited-capacity theater.
Looking ahead to May, the exit of Megan Thee Stallion from Moulin Rouge! will serve as a test case for how much a single star’s presence dictates the financial health of a long-running show. Simultaneously, the industry will pivot its focus to the Tony Awards, which will dictate the narrative of the Broadway season for the remainder of the year. With all shows now open and the nominations just days away, the Broadway community remains cautiously optimistic that the current momentum will carry through the lucrative summer season.
